CANNAINVESTOR Magazine U.S. Publicly Traded December 2017 | Page 118

CURRENT PUBLIC CANNABIS/HEMP COMPANY VALUATIONS

Axim Biotechnologies (AXIM) – Biotech company focusing on the application of cannabinoid based products

TTM Revenue = $40K

Current Market Cap =$371 M (approx.)

Share Price a/o 11/30/17 =$6.80

Kush Bottles, Inc. (KSHB) – Markets and Sells packaging products and solutions to customers in legal medicinal and recreational space.

TTM Revenue =$12.5 M

Current Market Cap =$174 M (approx.)

Share Price a/o 11/30/17 =$2.84

Cannabics Pharmaceuticals, Inc. (CNBX) engages in the research, development, licensing, and marketing of cannabinoid-based treatments and therapies

TTM Revenue =$50K

Current Market Cap =$125M (approx.)

Share Price a/o 11/30/17 =$1.02

118